Skip to content

Clinical trials

COVID-19 trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Argentina Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202068
202135
20229
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Terminated19
Unknown status16
Recruiting5
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Italiano de Buenos Aires10
Pfizer5
AstraZeneca3
Laboratorio Elea Phoenix S.A.3
Merck Sharp & Dohme LLC3
Ministry of Public Health, Argentina3
Sanatorio Anchorena San Martin3
University of Minnesota3
Atea Pharmaceuticals, Inc.2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19117
Coronavirus Infections13
Severe Acute Respiratory Syndrome10
Pneumonia8
Respiratory Distress Syndrome7
Virus Diseases6
Respiratory Tract Infections5
Infections4
Pneumonia, Viral4
RNA Virus Infections4

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.